Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Tapson

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Chest|February 23, 2021
Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19: A Randomized, Controlled Pilot TrialSara Ghandehari, Yuri Matusov, Samuel Pepkowitz, et al.
The American Journal of Cardiology|August 11, 2018
Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary HypertensionIrfan Siddiqui, Sudarshan Rajagopal, Amanda Brucker, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 2, 2024
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON studyRaymond L Benza, Kelly M Chin, Sean Gaine, et al.
Pulmonary Circulation|July 7, 2017
Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulationFranck F Rahaghi, Jeremy P Feldman, Roblee P Allen, et al.
Respiratory Research|November 20, 2020
Treatment-related biomarkers in pulmonary hypertension patients on oral therapiesAparna C Swaminathan, Hongmei Zhu, Victor Tapson, et al.
The European Respiratory Journal|April 20, 2023
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension studyAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2025
Diagnosis of chronic thromboembolic pulmonary hypertensionXavier Jais, Victor Tapson, Timothy M Fernandes, et al.
American Journal of Respiratory and Critical Care Medicine|January 30, 2014
Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolismDavid Jiménez, Dita Kopecna, Victor Tapson, et al.
The New England Journal of Medicine|January 13, 2021
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung DiseaseAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
Chest|February 5, 2021
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON StudySean Gaine, Olivier Sitbon, Richard N Channick, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Chest|February 23, 2021
Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19: A Randomized, Controlled Pilot TrialSara Ghandehari, Yuri Matusov, Samuel Pepkowitz, et al.
The American Journal of Cardiology|August 11, 2018
Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary HypertensionIrfan Siddiqui, Sudarshan Rajagopal, Amanda Brucker, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 2, 2024
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON studyRaymond L Benza, Kelly M Chin, Sean Gaine, et al.
Pulmonary Circulation|July 7, 2017
Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulationFranck F Rahaghi, Jeremy P Feldman, Roblee P Allen, et al.
Respiratory Research|November 20, 2020
Treatment-related biomarkers in pulmonary hypertension patients on oral therapiesAparna C Swaminathan, Hongmei Zhu, Victor Tapson, et al.
The European Respiratory Journal|April 20, 2023
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension studyAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2025
Diagnosis of chronic thromboembolic pulmonary hypertensionXavier Jais, Victor Tapson, Timothy M Fernandes, et al.
American Journal of Respiratory and Critical Care Medicine|January 30, 2014
Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolismDavid Jiménez, Dita Kopecna, Victor Tapson, et al.
The New England Journal of Medicine|January 13, 2021
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung DiseaseAaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, et al.
Chest|February 5, 2021
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON StudySean Gaine, Olivier Sitbon, Richard N Channick, et al.
Pageof 5